Effect of nitroglycerin and long-term electrical stimulation on nitrergic relaxation in the pig gastric fundus

British Journal of Pharmacology

Volumn 123, Issue 1, 1998, Pages 143-149

  Lefebvre, R A ^a   Vandekerckhove, K ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Gastric fundus; Long term electrical stimulation; Nitrergic neurotransmission; Nitric oxide; Nitroglycerin

Indexed keywords

ATROPINE; GLYCERYL TRINITRATE; GUANETHIDINE; LEMAKALIM; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; ENZYME INHIBITION; MALE; NERVE STIMULATION; NEUROTRANSMISSION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; STOMACH FUNDUS; SWINE;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; CROMAKALIM; ELECTRIC STIMULATION; GASTRIC FUNDUS; MALE; MUSCLE RELAXATION; NITRIC OXIDE; NITROGLYCERIN; ORCHIECTOMY; STOMACH; SWINE; VASOACTIVE INTESTINAL PEPTIDE; VASODILATOR AGENTS;

EID: 0031984424     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701582     Document Type: Article

References (38)

1. AHLNER, J., ANDERSSON, R.G.G., AXELSSON, K.L., DAHLSTRÖM, U. & RYDELL, E.L. (1986). Development of tolerance to glyceryl trinitrate in an isolated human peripheral vein and its relation to cyclic GMP metabolism. Acta Pharmacol. Toxicol., 59, 123-128.
2. ASSREUY, J., CUNHA, E.Q., LIEW, F.Y. & MONCADA, S. (1993). Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br. J. Pharmacol., 108, 833-837.
3. AXELSSON, K.L. & AHLNER, J. (1987). Nitrate tolerance from a biochemical point of view. Drugs, 33 (Suppl. 4), 63-68.
4. BARBIER, A.J. & LEFEBVRE, R.A. (1993). Involvement of the L-arginine:nitric oxide pathway in nonadrenergic noncholinergic relaxation of the cat gastric fundus. J. Pharmacol. Exp. Ther., 266, 172-178.
5. BERKENBOOM, G., FONTAINE, J. & DEGRE, S. (1988). Persistence of the response to SIN-1 on isolated coronary arteries rendered tolerant to nitroglycerin in vitro or in vivo. J. Cardiovasc. Pharmacol., 12, 345-349.
6. BITAR, K.N. & MAKHLOUF, G.M. (1982). Relaxation of isolated gastric muscle cells by vasoactive intestinal peptide. Science, 216, 531-533.
7. BOECKXSTAENS, G.E., PELCKMANS, P.A., DE MAN, J.G., BULT, H., HERMAN, A.G. & VAN MAERCKE, Y.M. (1992). Evidence for a differential release of nitric oxide and vasoactive intestinal polypeptide by nonadrenergic noncholinergic nerves in the rat gastric fundus. Arch. Int. Pharmacodyn., 318, 107-115.
8. BROOKES, S.J.H. (1993). Neuronal nitric oxide in the gut. J. Gastroenterol. Hepatol., 8, 590-603.
9. BUGA, G.M., GRISCAVAGE, J.M., ROGERS, N.E. & IGNARRO, L.J. (1993). Negative feedback regulation of endothelial cell function by nitric oxide. Circ. Res., 73, 808-812.
10. DE MAN, J.G., BOECKXSTAENS, G.E., DE WINTER, B.Y., MOREELS, T.G., HERMAN, A.G. & PELCKMANS, P.A. (1995). Inhibition of non-adrenergic non-cholinergic relaxations by nitric oxide donors. Eur. J. Pharmacol., 285, 269-274.
11. ECKLY, A.E. & LUGNIER, C. (1994). Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Br. J. Pharmacol., 113, 445-450.
12. GRUNDY, D., GHARIB-NASERI, M.K. & HUTSON, D. (1993). Role of nitric oxide and vasoactive intestinal polypeptide in vagally mediated relaxation of the gastric corpus in the anaesthetized ferret. J. Autonom. Nerv. Syst., 43, 241-246.
13. JANG, E.K., DAVIDSON, M.M.L., CRANKSHAW, D. & HASLAM, R.J. (1993). Synergistic inhibitory effects of atriopeptin II and isoproterenol on contraction of rat aortic smooth muscle: roles of cGMP and cAMP. Eur. J. Pharmacol., 250, 477-481.
14. JIN, J.-G., MURTHY, K.S., GRIDER, J.R. & MAKHLOUF, G.M. (1993). Activation of distinct cAMP- and cGMP-dependent pathways by relaxant agents in isolated gastric muscle cells. Am. J. Physiol., 264, G470-G477.
15. KASAKOV, L., CELLEK, S. & MONCADA, S. (1995). Characterization of nitrergic neurotransmission during short- and long-term electrical stimulation of the rabbit anococcygeus muscle. Br. J. Pharmacol., 115, 1149-1154.
16. KELM, M. & SCHRADER, J. (1990). Control of coronary vascular tone by nitric oxide. Circ. Res., 66, 1561-1575.
17. KOWALUK, E.A. & FUNG, H.-L. (1990). Dissociation of nitrovasodilator-induced relaxation from cyclic GMP levels during in vitro nitrate tolerance. Eur. J. Pharmacol., 176, 91-95.
18. KRÖNCKE, K.-D., FEHSEL, K. & KOLB-BACHOFEN, V. (1995). Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol. Chem. Hoppe-Seyler, 376, 327-343.
19. KUHN, M. & FÖRSTERMANN, U. (1989). Endothelium-dependent vasodilatation in human epicardial coronary arteries: effect of prolonged exposure to glyceryl trinitrate or SIN-1. J. Cardiovasc. Pharmacol., 14 (Suppl. 11). S47-S54.
20. KUKOVETZ, W.R. & HOLZMANN, S. (1989). Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries. J. Cardiovasc. Pharmacol., 14 (Suppl. 11), S40-S46.
21. LANGER, S.Z. (1981). Presynaptic regulation of the release of catecholamines. Pharmacol. Rev., 32, 337-362.
22. G-nitro-L-arginine on non-adrenergic non-cholinergic relaxation in the guinea-pig gastric fundus. Br. J. Pharmacol., 106, 173-179.
23. LEFEBVRE, R.A., SMITS, G.J.M. & TIMMERMANS, J.-P. (1995). Study of NO and VIP as non-adrenergic non-cholinergic neurotransmitters in the pig gastric fundus. Br. J. Pharmacol., 116, 2017-2026.
24. LI, C.G. & RAND, M.J. (1990). Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur. J. Pharmacol., 191, 303-309.
25. MA, X.-L., LOPEZ, B.L., CHRISTOPHER, T.A., BIRENBAUM, D.S. & VINTEN-JOHANSEN, J. (1996). Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo. Am. J. Physiol., 271, H2045-H2051.
26. MANDREK, K. & MILENOV, K. (1991). Responses of porcine gastric and duodenal smooth muscle to VIP. J. Autonom. Pharmacol., 11, 353-364.
27. MONCADA, S., PALMER, R.M.J. & HIGGS, A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142.
28. 2+ influx activates a constitutive NOS in dispersed gastric muscle cells. Am. J. Physiol., 265, G660-G671.
29. NEEDLEMAN, P., JAKSCHIK, B. & JOHNSON, E.M., Jr. (1973). Sulfhydryl requirement for relaxation of vascular smooth muscle. J. Pharmacol. Exp. Ther., 187, 324-331.
30. PAPAPETROPOULOS, A., GO, C.Y., MURAD, F. & CATRAVAS, J.D. (1996). Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells. Br. J. Pharmacol., 117, 147-155.
31. + channels. Trends Pharmacol. Sci., 10, 431-435.
32. RAND, M.J. & LI, C.G. (1995). Nitric oxide as a neurotransmitter in peripheral nerves: Nature of transmitter and mechanism of transmission. Ann. Rev. Physiol., 57, 659-682.
33. RENGASAMY, A. & JOHNS, R.A. (1993). Regulation of nitric oxide synthase by nitric oxide. Mol. Pharmacol., 44, 124-128.
34. ROGERS, N.E. & IGNARRO, L.J. (1992). Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem. Biophys. Res. Commun., 189, 242-249.
35. ROMANIN, C. & KUKOVETZ, W.R. (1989). Tolerance to nitroglycerin is caused by reduced guanylate cyclase activation. J. Mol. Cell. Cardiol., 21, 41-48.
36. STARKE, K. (1981). Presynaptic receptors. Ann. Rev. Pharmacol. Toxicol., 21, 7-30.
37. WRIGHT, I.K., AMIRCHETTY-RAO, S. & KENDALL, D.A. (1994). Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein. Br. J. Pharmacol., 112, 1146-1150.
38. ZHANG, L.M., CASTRESANA, M.R., STEFANSSON, S. & NEWMANN, W.H. (1993). Tolerance to sodium nitroprusside. Studies in cultured porcine vascular smooth muscle cells. Anesthesiology, 79, 1094-1103.